While the development poses no threat to the NDA alliance at the centre or its government in Manipur, but the move is a ...

Vanda Pharmaceuticals (VNDA) issued a letter to FDA Commissioner highlighting what the company considers a faulty gastroparesis NDA review.

State chief writes to the Governor to “further reiterate” the party’s stand even as central leadership and lone legislator’s ...

Today, Vanda issued a letter to FDA Commissioner Robert M. Califf, MD, regarding the September 18, 2024 CRL in reference to Vanda's NDA for tradipitant for the treatment of gastroparesis. The full ...

8, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) letter to FDA Commissioner highlights faulty gastroparesis NDA review. As previously reported, Vanda has sought approval ...

The JD(U) on Wednesday sacked its Manipur unit chief Kshetrimayum Biren Singh for writing a letter saying the party doesn't ...